• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (23)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Glaucoma  • Alert me on articles by topic  Social Bookmarking   What's this?

Kaija Polak, MD; Alexandra Luksch, MD; Fatmire Berisha, MD; Gabriele Fuchsjaeger-Mayrl, MD; Susanne Dallinger, MD; Leopold Schmetterer, PhD

Arch Ophthalmol. 2007;125(4):494-498.

Objective  To investigate the ocular blood flow response to systemic nitric oxide synthase inhibition in patients with primary open-angle glaucoma.

Methods  In 12 patients with glaucoma and 12 age-matched control subjects, subfoveal choroidal blood flow, optic nerve head blood flow, ocular fundus pulsation amplitude, intraocular pressure, and systemic hemodynamic parameters were measured at baseline and after inhibition of nitric oxide synthase by intravenous administration of NG-monomethyl-L-arginine.

Results  The increase in blood pressure in response to NG-monomethyl-L-arginine was comparable between the 2 study cohorts. In patients with glaucoma, the decrease of optic nerve head blood flow (P = .03) and fundus pulsation amplitude (P<.001) during nitric oxide synthase inhibition was significantly less pronounced than in healthy control subjects. A tendency toward a reduced response in choroidal blood flow was seen (P = .051 between groups) in patients with glaucoma.

Conclusions  This is the first in vivo study providing evidence for an altered ocular L-arginine/nitric oxide system in patients with glaucoma. Normalization of the ocular nitric oxide production may be beneficial in terms of normalization of ocular blood flow and neuroprotection of retinal ganglion cells.

Author Affiliations: Departments of Clinical Pharmacology (Drs Polak, Luksch, Berisha, Fuchsjaeger-Mayrl, Dallinger, and Schmetterer), Ophthalmology (Drs Polak, Luksch, and Fuchsjaeger-Mayrl), and Biomedical Engineering and Physics (Dr Schmetterer), Medical University of Vienna, Vienna, Austria.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

eNOS, a Pressure-Dependent Regulator of Intraocular Pressure
Stamer et al.
IOVS 2011;52:9438-9444.
ABSTRACT | FULL TEXT  

Inducible Nitric Oxide Synthase-Mediated Alteration of Mitochondrial OPA1 Expression in Ocular Hypertensive Rats
Dai et al.
IOVS 2011;52:2468-2476.
ABSTRACT | FULL TEXT  

Ability of Dorzolamide Hydrochloride and Timolol Maleate to Target Mitochondria in Glaucoma Therapy
Sacca et al.
Arch Ophthalmol 2011;129:48-55.
ABSTRACT | FULL TEXT  

Modulation of Factors Affecting Optic Nerve Head Astrocyte Migration
Miao et al.
IOVS 2010;51:4096-4103.
ABSTRACT | FULL TEXT  

Endothelial Nitric Oxide Synthase Gene Variants and Primary Open-Angle Glaucoma: Interactions with Sex and Postmenopausal Hormone Use
Kang et al.
IOVS 2010;51:971-979.
ABSTRACT | FULL TEXT  

Role of Calcium-Activated Potassium Channels with Small Conductance in Bradykinin-Induced Vasodilation of Porcine Retinal Arterioles
Dalsgaard et al.
IOVS 2009;50:3819-3825.
ABSTRACT | FULL TEXT